SLC7A15P

Across TCGA pan-cancer cohorts, SLC7A15P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SLC7A15P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SLC7A15P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SLC7A15P expression acts as an unfavorable survival marker, although some lineages such as ACC and BLCA show a favorable association.

LUAD, UCS, and CESC are the cancer types where SLC7A15P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.537	0.805	<.001	138	view →
UCS	OS	Tertile	All	0.246	0.714	<.001	108	view →
CESC	OS	Tertile	IV	0.249	0.652	.007	66	view →
KIRC	OS	Tertile	All	0.521	0.665	<.001	53	view →
THCA	OS	Tertile	All	0.565	0.938	.001	36	view →
READ	OS	Tertile	II,III,IV	0.521	0.930	.004	36	view →
SKCM	OS	Tertile	III,IV	0.433	0.727	.001	21	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	18	view →
GBM	OS	Tertile	All	0.160	0.422	<.001	18	view →
LUSC	OS	Tertile	III,IV	0.054	0.768	<.001	18	view →
ACC	OS	Tertile	II,III,IV	1.000	0.714	.014	18	view →
SARC	DFS	Tertile	All	0.209	0.377	.008	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SLC7A15P–LUAD (OS)

Open the LUAD breakdown →